Switching to E-Cigarettes or Quitting smoking Reduces Cardiac Risks After PCI, suggests study
Researchers have found that patients with coronary artery disease (CAD) who had transitioned entirely to e-cigarettes or quit smoking altogether after percutaneous coronary intervention (PCI) had fewer major adverse cardiac events (MACE) compared to those who continued smoking combustible cigarettes. A recent study was conducted by Danbee Kang and colleagues which was published in the European Heart Journal.
Smoking is a major modifiable risk factor for cardiovascular disease, including coronary artery disease. Quitting smoking has been shown to improve the outcome, but how E-cigarettes serve as an alternative remains unclear. In this study, researchers examined whether switching to E-cigarettes has an impact on post-PCI outcomes, specifically on the risk of MACE.
Grouping from the Korean National Health Insurance database, 17,973 adult smokers (≥20 years) who underwent PCI and had completed health screens within 3 years before and after PCI. Participants were categorized into three groups:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.